Estro-Balance
Natural health product licensed in Canada
- Other names
- Women's Blend
- Licence holder
- Natural Immix Health Ltd.
- NPN or DIN-HM
- 80073717
- Status
- Active licence
- Licence date
- 10 November 2016
- Revision date
- 7 February 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 134.22 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Vitamine B12: the published amount (12,5 milligramme) is more than a thousand times the maximum supplement dose: this is very likely a unit error in the source. No dose comparison is made for this nutrient.
contrôle de vraisemblance. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 5 milligramme | 10,000 µg |
| Calcium Source : Citrate de calcium | 50 milligramme | 100,000 µg |
| Calcium Source : Carbonate de calcium | 50 milligramme | 100,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 12.5 milligramme | 25,000 µg |
| Vitamine E Source : d-alpha tocophérol Potency : 100 UI | 67.11 milligramme | 134,220 µg |
| Vitex agnus-castus Source : Fruit | 5 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 25 UI | 0.625 microgrammes | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 5 milligramme | 10,000 µg |
| Niacinamide Source : Niacinamide | 5 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 milligramme | 10,000 µg |
| Magnésium Source : Oxyde de magnésium | 50 milligramme | 100,000 µg |
| Magnésium Source : Citrate de magnésium | 50 milligramme | 100,000 µg |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 0.035:1 Dry plant equivalent : 8.75 milligramme Potency : 8.75 milligramme Isoflavones | 250 milligramme | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 0.025:1 Dry plant equivalent : 1 milligramme Potency : 1 milligramme Triteroene Glycosides | 40 milligramme | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Extrait d'isoflavones de trèfle rouge Potency : 4 milligramme Isoflavones | 50 milligramme | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine | 5 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine | 5 milligramme | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, Hypromellose, Croscarmellose de sodium, Carbonate de calcium, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May reduce severe and frequent menopausal symptoms (such as hot flashes/ flushes and/or night sweats). Used in Herbal Medicine to help relieve premenstrual symptoms and to help relieve symptoms associated with menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80073717
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.